Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    nichd Primary Immunodeficiency (PI)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART
Conditions: HIV Infections;   Malaria
Interventions: Drug: Lamivudine;   Drug: Lopinavir/Ritonavir;   Drug: Nevirapine;   Drug: Zidovudine
2 Completed Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women
Conditions: Malaria;   HIV Infections
Interventions: Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Zidovudine;   Drug: Lamivudine
3 Completed HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: LPV/r + 2 NRTIs;   Drug: NVP or EFV + 2 NRTIs
4 Terminated Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
Condition: HIV Infections
Interventions: Drug: AZT/3TC/NVP (zidovudine/lamivudine/nevirapine);   Drug: d4T/3TC/NVP (stavudine/lamivudine/nevirapine);   Drug: AZT/3TC/ABC (zidovudine/lamivudine/abacavir);   Drug: d4T/3TC/ABC (stavudine/lamivudine/abacavir);   Drug: ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir);   Drug: ABC/ ddI or TDF / NVP or EFV (abacavir / didanosine or tenofovir / nevirapine or efavirenz);   Drug: ABC/3TC/NVP (abacavir/lamivudine/nevirapine)
5 Unknown  Pediatric Nevirapine Resistance Study
Conditions: AIDS;   HIV Infections
Intervention: Drug: nevirapine

Indicates status has not been verified in more than two years